Humata Health builds an AI-powered, end-to-end prior authorization platform that automates submissions and integrates bi-directionally with common EHRs and clinical documentation systems. Its proprietary generative AI and machine learning engine recommends clinical documents to improve submission quality, monitors post-approval changes to flag downstream denial risks, and leverages broad payer connectivity to automate interactions. More than 42,000 physicians at 225 hospitals across the U.S. rely on Humata’s technology, and the company has augmented its platform with assets purchased through acquisition. Humata plans to broaden the scope of its generative AI technologies, expand its customer base among leading healthcare providers, and begin partnering with payers and delegated entities to deliver complementary solutions. The company is physician-led by founder Dr. Jeremy Friese and focuses on improving first-pass approvals while reducing payer workload. A recent CMS rule shortening authorization decision timelines is expected to increase demand for Humata’s automation solutions.

Total raised

$25M

Funding rounds

1

Latest round

Equity

Latest activity

Jun 2024